This regular update (no. 84 | 17 May 2022 ) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective Equipment; and Cybersecurity, Privacy & Data Protection).
LATEST KEY DEVELOPMENTS
Competition & State Aid
- European Commission to phase out State aid COVID Temporary Framework
- European Commission approves new and amended Member State measures to support the economy
- European Commission approves further schemes under State aid Temporary Crisis Framework in context of Russia's invasion of Ukraine
Trade / Export Controls
- EU-US Trade and Technology Council issue Joint Statement following second ministerial-level meeting
- Affirmed commitment to US-EU Agenda for Beating the Global Pandemic
Medicines and Medical Devices
- EMA endorses Joint Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness
- European Commission announces agreement with BioNTech and Pfizer on delivery of COVID-19 vaccines
Cybersecurity, Privacy & Data Protection
- European Parliament and Council provisionally agree on proposed Directive for high common level of cybersecurity across the Union
- European Commission proposes Regulation on European Health Data Space
Attachments: COVID19 KEY EU DEVELOPMENTS No 84 17 May 2022
Originally published May 2022
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.